2024
|
Invention
|
Monoclonal antibodies against human tim-3.
Provided are anti-human Tim-3 IgV domain-specific ant... |
|
Invention
|
Transdermal delivery formulations.
A transdermal formulation for the delivery of one or more act... |
|
Invention
|
Tmem active test and uses thereof in diagnosis, prognosis and treatment of tumors.
Disclosed are... |
|
Invention
|
Bax activators and uses thereof in cancer therapy.
Activators of BAX and their uses in cancer th... |
|
Invention
|
Phenylethanolamine n-methyltransferase (pnmt) inhibitors to regulate adrenaline responses. Disclo... |
|
Invention
|
Mitofusin inhibitors and uses thereof.
Disclosed herein are mitofusin inhibitors which are capab... |
|
Invention
|
Novel mitofusin inhibitors. Disclosed herein are mitofusin inhibitors which are capable of induci... |
|
Invention
|
Bax activators and use thereof. Disclosed herein are small molecule activators of the B-cell lymp... |
|
Invention
|
Antibodies targeting s100 proteins and uses thereof. This disclosure provides novel neutralizing ... |
|
Invention
|
Low intensity focused ultrasound for treating cancer and metastasis.
Systems and methods for tre... |
|
Invention
|
Method of screening for changes in enzymatic activity in live cells. The present disclosure descr... |
|
Invention
|
Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus... |
|
Invention
|
Small molecule bax inhibitors and uses thereof.
Compounds, compositions and method of using thes... |
|
Invention
|
Circulating levels of endothelial microrna predict new-onset diabetes in covid-19 and long covid.... |
|
Invention
|
Compositions for blood storage and transfusions. Formulations comprising one or more active agent... |
|
Invention
|
Methods for expanding hematopoietic stem cells using revitalized mesenchymal stem cells.
A metho... |
|
Invention
|
Tmigd2 and its derivatives as blockers or binders of cancer-expressed hhla2 for immunotherapies. ... |
2023
|
Invention
|
Thrombopoietin mimetic for use in the treatment of acute liver failure. A method of treating pati... |
|
Invention
|
Persistance and linking of analytic products in big data environments.
Persistence and linking o... |
|
Invention
|
Transdermal delivery formulations. A transdermal formulation for the delivery of one or more acti... |
|
Invention
|
Nitric oxide-releasing device.
A device for generating nitric oxide is disclosed. The device is ... |
|
Invention
|
Approach to sustained production and delivery of nitric oxide and s-nitrosothiols.
A composition... |
|
Invention
|
Transdermal delivery formulations.
A transdermal formulation for the delivery of a nitric oxide ... |
|
Invention
|
Mitofusin activators and uses thereof.
Activators of mitofusins and their uses in treatment of d... |
|
Invention
|
Neoadjuvant chemotherapy induces breast cancer metastasis through a tmem-mediated mechanism.
Met... |
|
Invention
|
Monoclonal antibodies to arabinomannan (am), groel2, and lprg and methods of use. Provided are an... |
|
Invention
|
Rna tagging system for visualization of single mrna molecules.
An RNA tagging system for visuali... |
|
Invention
|
Circulating levels of mirna-24 predict cerebrovascular events in covid-19. Provided herein are co... |
|
Invention
|
Flt3 ligand bi-functional molecules for thrombopenia and acute radiation syndrome. Provided herei... |
|
Invention
|
Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput c... |
|
Invention
|
Use of chaperone-mediated autophagy activators for treating or preventing blood cancers and myelo... |
|
Invention
|
Methods and devices for intraoperative viewing of patient 3d surface images.
Methods and devices... |
|
Invention
|
Double auxotrophic mycobacterium and uses thereof. Mycobacterium to determine the efficacy. |
|
Invention
|
Infectious recombinant vesicular stomatitis virus (rvsv) bearing the spike glycoprotein s of sars... |
2022
|
Invention
|
Cell impermeable kinase inhibitors to treat sars-cov-2 and/or hsv viral infections.
Methods of p... |
|
Invention
|
Methods, compositions, and kits for modifying immune cell activity via kir2dl5.
Provided herein ... |
|
Invention
|
Methods for the generation of human retinal ganglion cells and compositions, assays, devices, and... |
|
Invention
|
Method of treating and/or preventing type 1 diabetes with cepharanthine.
This disclosure provide... |
|
Invention
|
Compositions and methods for the treatment of herpes simplex virus infection.
Provided herein ar... |
|
Invention
|
Compositions and methods for inhibiting the expression of tmigd2.
Methods of treating cancer by ... |
|
Invention
|
Single-domain antigen-dependent antibody-like fusion proteins.
Provided herein are fusion protei... |
|
Invention
|
Single-component near-infrared optogenetic systems for gene transcription regulation.
This discl... |
|
Invention
|
Variants of sirt6 for use in preventing and/or treating age-related diseases.
An isolated nuclei... |
|
Invention
|
Compositions and methods for treating and/or identifying an agent for treating hiv-1 infections. ... |
|
Invention
|
Method of increasing chaperone mediated autophagy by stabilizing the interaction of retinoic acid... |
|
Invention
|
The immunomodulatory ligand b7-1 mediates synaptic remodeling by p75ntr.
As described herein, bi... |
|
Invention
|
Methods of stabilizing the neuronal proteome against collapse and protecting vascular cells.
The... |
|
Invention
|
Clinical decision support systems employing reverse phenotyping.
Clinical decision support syste... |
2021
|
Invention
|
High-affinity mycobacterium tuberculosis capsule-specific human monoclonal antibody.
Provided ar... |
|
Invention
|
Compounds and methods for inhibition of bax-mediated cell death.
This disclosure provides novel ... |